APA (7th ed.) Citation

Lee, J. K., Yoon, J. Y., Lee, J. Y., & Lee, S. H. (2026). PrP C -Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation. International Journal of Molecular Sciences, 27(3), 1159. https://doi.org/10.3390/ijms27031159

Chicago Style (17th ed.) Citation

Lee, Jeong Kun, Jun Young Yoon, Jae Young Lee, and Sang Hun Lee. "PrP C -Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation." International Journal of Molecular Sciences 27, no. 3 (2026): 1159. https://doi.org/10.3390/ijms27031159.

MLA (9th ed.) Citation

Lee, Jeong Kun, et al. "PrP C -Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation." International Journal of Molecular Sciences, vol. 27, no. 3, 2026, p. 1159, https://doi.org/10.3390/ijms27031159.